DOCSLIB.ORG

Iron Regulatory Protein 2 Modulates the Switch from Aerobic Glycolysis to Oxidative Phosphorylation in Mouse Embryonic Fibroblasts

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Iron Regulatory Protein 2 Modulates the Switch from Aerobic Glycolysis to Oxidative Phosphorylation in Mouse Embryonic Fibroblasts Iron regulatory protein 2 modulates the switch from aerobic glycolysis to oxidative phosphorylation in mouse embryonic fibroblasts Huihui Lia, Yutong Liua, Longcheng Shangb, Jing Caib, Jing Wua, Wei Zhanga, Xiaojiang Pua, Weichen Donga, Tong Qiaob, and Kuanyu Lia,1 aJiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing 210093, People’s Republic of China; and bDepartment of Vascular Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, People’s Republic of China Edited by Nancy C. Andrews, Duke University School of Medicine, Durham, NC, and approved April 9, 2019 (received for review December 1, 2018) The importance of the role of iron regulatory proteins (IRPs) in In our previous study, we found that the Irp1-orIrp2-null mitochondrial iron homeostasis and function has been raised. To mutation in mouse embryonic fibroblasts (MEFs) caused de- understand how an IRP affects mitochondrial function, we used creased expression of frataxin (Fxn) and iron–sulfur cluster globally Irp2-depleted mouse embryonic fibroblasts (MEFs) and scaffold protein IscU, two important components of the Fe–S found that Irp2 ablation significantly induced the expression of biogenesis machinery (11). Deficiency of Fxn or IscU in human both hypoxia-inducible factor subunits, Hif1α and Hif2α. The in- and mouse cells limits mitochondrial function due to the lack of crease of Hif1α up-regulated its targeted genes, enhancing glycol- sufficient Fe–S clusters (12, 13). Furthermore, IRP depletion- ysis, and the increase of Hif2α down-regulated the expression of induced deficiency of Fxn and IscU specifically adversely af- iron–sulfur cluster (Fe–S) biogenesis-related and electron transport fects the activity of the Fe–S-dependent mitochondrial re- chain (ETC)-related genes, weakening mitochondrial respiration. spiratory chain, while the activities of other Fe–S-dependent Inhibition of Hif1α by genetic knockdown or a specific inhibitor enzymes, such as aconitase and xanthine dehydrogenase, are prevented Hif1α-targeted gene expression, leading to decreased enhanced (11). Strangely, ATP is more highly produced in α Irp2−/− aerobic glycolysis. Inhibition of Hif2 by genetic knockdown or MEFs than in WT (the present study). This result CELL BIOLOGY selective disruption of the heterodimerization of Hif2α and Hif1β seeming paradoxical to the low activity of the electron transport restored the mitochondrial ETC and coupled oxidative phosphory- chain (ETC) and high content of ATP, suggesting a shift of the lation (OXPHOS) by enhancing Fe–S biogenesis and increasing ETC- metabolic pathway in Irp2 ablation cells. related gene expression. Our results indicate that Irp2 modulates Oxidative phosphorylation (OXPHOS) and glycolysis are two the metabolic switch from aerobic glycolysis to OXPHOS that is key metabolic pathways for energy production. The switch from mediated by Hif1α and Hif2α in MEFs. one pathway to another is controlled by a number of factors, including two important transcription factors, HIF1 and HIF2. iron regulatory protein 2 | mitochondrial function | energy metabolism | HIFs are heterogeneous dimers that are mainly composed of hypoxia inducible factors an O2-labile alpha subunit (HIF1α or HIF2α)andastable beta subunit (HIF1β, also known as ARNT). The direct con- α ron is essential for growth and proliferation of mammalian nection between Irp and Hif demonstrates that Hif2 is Icells due to its important roles in protein cofactors, hemes and iron–sulfur clusters (Fe–S), which are involved in a number of Significance biochemical pathways, including hemoglobin synthesis and the mitochondrial respiration chain. Cellular iron homeostasis is Iron regulatory proteins (IRPs) control cellular iron homeostasis. secured by two orthologous iron regulatory proteins (IRPs), Irp2 knockout mice show symptoms of neurological disorders, IRP1 and IRP2, both of which are iron-regulated RNA-binding which are considered to result from impaired mitochondrial proteins that posttranscriptionally control the expression of a activity. To explore the involvement of Irp2 in mitochondrial series of iron-related genes, such as ferritin, transferrin receptor function, we examined the metabolic pathways of Irp2- 1(TfR1), ferroportin 1 (FPN1), DMT1, and eALAS (1, 2). When depleted mouse embryonic fibroblasts. We found that Irp2 cells are iron-deficient in the labile pool, IRPs bind iron- deficiency switches cellular metabolic pathways from oxidative responsive elements (IREs) located in the 5′-UTR of ferritin phosphorylation (OXPHOS) to aerobic glycolysis. We further and FPN1 mRNA to inhibit its translation, which reduces iron revealed that Irp2 deficiency induces the expression of Hif1α storage and export, and the IRE in the 3′-UTR of TfR1 and and Hif2α; Hif1α enhances aerobic glycolysis by upregulating DMT1, which stabilizes the mRNA to facilitate iron import. its target genes related to the glycolytic pathway, and Hif2α When cells are iron-abundant, IRP1 is converted to a [4Fe-4S]- suppresses mitochondrial Fe–S biosynthesis and OXPHOS. This containing aconitase, and IRP2 is removed through iron- identified mechanism implies that high-energy-need tissues, mediated proteasomal degradation (3, 4), which increases ferri- such as the central nervous system, could be affected when tin and FPN1 translation and promotes TfR1 and DMT1 mRNA Irp2 is deficient, leading to neurological disorders. degradation, preventing additional iron absorption and avoiding excess iron-induced injury. Author contributions: H.L. and K.L. designed research; H.L., Y.L., L.S., J.C., J.W., W.Z., X.P., Studies have shown that mice lacking Irp2 have abnormal iron and W.D. performed research; T.Q. and K.L. contributed new reagents/analytic tools; H.L., contents in several tissues and develop microcytic anemia and T.Q., and K.L. analyzed data; and H.L. and K.L. wrote the paper. erythropoietic protoporphyria (5, 6). Irp2 knockout mice also The authors declare no conflict of interest. have symptoms of neurological disorders (7–9) due to the This article is a PNAS Direct Submission. functional iron starvation in brain and spinal cord. This func- Published under the PNAS license. tional iron starvation is therefore considered to be causative of 1To whom correspondence should be addressed. Email: [email protected]. the impaired mitochondrial activity (10). However, the exact This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. mechanism by which Irp2 sustains normal mitochondrial func- 1073/pnas.1820051116/-/DCSupplemental. tion is still unclear. Published online April 30, 2019. www.pnas.org/cgi/doi/10.1073/pnas.1820051116 PNAS | May 14, 2019 | vol. 116 | no. 20 | 9871–9876 Downloaded by guest on September 28, 2021 posttranscriptionally regulated by Irp1 through binding the IRE in the 5′-UTR of Hif2α mRNA (14, 15). Irp1 ablation mice de- velop polycythemia, cardiac fibrosis, and pulmonary hyperten- sion, which are attributed to a high level of Hif2α, which mediates the up-regulation of erythropoietin (16–18). Although Hif2α is up-regulated in Irp2-depleted cells (18), the physiolog- ical roles of both Hifs in Irp2 ablation mice remain unknown. Here, we address the role of up-regulated Hif1α and Hif2α in −/− Irp2 MEFs in regard to energy metabolism. Using MEFs in which Irp2 is globally depleted, we demonstrated that increased Hif1α enhanced glycolysis by targeting a number of glycolytic pathway-related genes, while increased Hif2α inhibited mito- chondrial OXPHOS by decreasing, likely indirectly, the expres- sion of Fxn and IscU and affecting the mitochondrial Fe–S cluster assembly and by decreasing the expression of ETC sub- units and weakening OXPHOS. Therefore, Irp2 deficiency switches energy metabolism from OXPHOS to glycolysis. Results Irp2 Ablation-Induced Mitochondrial Dysfunction Is Associated with the Metabolic Switch from OXPHOS to Aerobic Glycolysis in MEFs. IRPs have been demonstrated to be important for mitochondrial iron supply and function (19). Consistent with this finding, we and other groups revealed in vivo and in vitro that a deficit of available iron and reduction of mitochondrial Fe–S biogenesis can be key factors in mitochondrial dysfunction in general (20) and in Irp2 ablated cells (10, 11). Here, we confirmed that the activities of mitochondrial complexes I, II, and III significantly −/− decreased in Irp2 MEFs compared with WT (Fig. 1A), which is consistent with the levels of the Fe–S-containing subunits Ndufs1 (of complex I), SdhB (of complex II), and Uqcrfs1 (of Fig. 1. Irp2 ablation-induced mitochondrial dysfunction is associated with −/− complex III) in Irp2 cells (Fig. 1B and SI Appendix, Fig. S1). In enhanced aerobic glycolysis in MEFs. (A) Activities of ETC complexes in Irp2- deficient MEFs. CI, CII, and CIII, complexes I, II, and III. (B) Western blot addition, the amounts of other mitochondrial proteins, such as analysis of mitochondrial proteins, including Ndufs1 (a subunit of CI), SdhB (a cytochrome C (CytC, an intermembrane protein) and ferroche- −/− subunit of CII), Uqcrfs1 (a subunit of CIII), Fech (a matrix enzyme ferroche- latase (Fech, a matrix protein), also decreased in Irp2 cells latase), CytC (an intermembrane space protein cytochrome C), and Cs (a (Fig. 1B and SI Appendix, Fig. S1). To further detect any broad matrix non-Fe–S citrate synthase). A representative image set is presented. effect of Irp2 deficiency on mitochondrial function, we measured Actin was used
Load more

Recommended publications
  • Progressive Increase in Mtdna 3243A>G Heteroplasmy Causes Abrupt
    Progressive increase in mtDNA 3243A>G PNAS PLUS heteroplasmy causes abrupt transcriptional reprogramming Martin Picarda, Jiangwen Zhangb, Saege Hancockc, Olga Derbenevaa, Ryan Golhard, Pawel Golike, Sean O’Hearnf, Shawn Levyg, Prasanth Potluria, Maria Lvovaa, Antonio Davilaa, Chun Shi Lina, Juan Carlos Perinh, Eric F. Rappaporth, Hakon Hakonarsonc, Ian A. Trouncei, Vincent Procaccioj, and Douglas C. Wallacea,1 aCenter for Mitochondrial and Epigenomic Medicine, Children’s Hospital of Philadelphia and the Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104; bSchool of Biological Sciences, The University of Hong Kong, Hong Kong, People’s Republic of China; cTrovagene, San Diego, CA 92130; dCenter for Applied Genomics, Division of Genetics, Department of Pediatrics, and hNucleic Acid/Protein Research Core Facility, Children’s Hospital of Philadelphia, Philadelphia, PA 19104; eInstitute of Genetics and Biotechnology, Warsaw University, 00-927, Warsaw, Poland; fMorton Mower Central Research Laboratory, Sinai Hospital of Baltimore, Baltimore, MD 21215; gGenomics Sevices Laboratory, HudsonAlpha Institute for Biotechnology, Huntsville, AL 35806; iCentre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC 3002, Australia; and jDepartment of Biochemistry and Genetics, National Center for Neurodegenerative and Mitochondrial Diseases, Centre Hospitalier Universitaire d’Angers, 49933 Angers, France Contributed by Douglas C. Wallace, August 1, 2014 (sent for review May
    [Show full text]
  • Dual Role of the Mitochondrial Protein Frataxin in Astrocytic Tumors
    Laboratory Investigation (2011) 91, 1766–1776 & 2011 USCAP, Inc All rights reserved 0023-6837/11 $32.00 Dual role of the mitochondrial protein frataxin in astrocytic tumors Elmar Kirches1, Nadine Andrae1, Aline Hoefer2, Barbara Kehler1,3, Kim Zarse4, Martin Leverkus3, Gerburg Keilhoff5, Peter Schonfeld5, Thomas Schneider6, Annette Wilisch-Neumann1 and Christian Mawrin1 The mitochondrial protein frataxin (FXN) is known to be involved in mitochondrial iron homeostasis and iron–sulfur cluster biogenesis. It is discussed to modulate function of the electron transport chain and production of reactive oxygen species (ROS). FXN loss in neurons and heart muscle cells causes an autosomal-dominant mitochondrial disorder, Friedreich’s ataxia. Recently, tumor induction after targeted FXN deletion in liver and reversal of the tumorigenic phenotype of colonic carcinoma cells following FXN overexpression were described in the literature, suggesting a tumor suppressor function. We hypothesized that a partial reversal of the malignant phenotype of glioma cells should occur after FXN transfection, if the mitochondrial protein has tumor suppressor functions in these brain tumors. In astrocytic brain tumors and tumor cell lines, we observed reduced FXN levels compared with non-neoplastic astrocytes. Mitochondrial content (citrate synthase activity) was not significantly altered in U87MG glioblastoma cells stably overexpressing FXN (U87-FXN). Surprisingly, U87-FXN cells exhibited increased cytoplasmic ROS levels, although mitochondrial ROS release was attenuated by FXN, as expected. Higher cytoplasmic ROS levels corresponded to reduced activities of glutathione peroxidase and catalase, and lower glutathione content. The defect of antioxidative capacity resulted in increased susceptibility of U87-FXN cells against oxidative stress induced by H2O2 or buthionine sulfoximine.
    [Show full text]
  • Pharmacological Inhibition of Tumor Anabolism and Host Catabolism As A
    www.nature.com/scientificreports OPEN Pharmacological inhibition of tumor anabolism and host catabolism as a cancer therapy Alejandro Schcolnik‑Cabrera1,2, Alma Chavez‑Blanco1, Guadalupe Dominguez‑Gomez1, Mandy Juarez1, Ariana Vargas‑Castillo3, Rafael Isaac Ponce‑Toledo4, Donna Lai5, Sheng Hua5, Armando R. Tovar3, Nimbe Torres3, Delia Perez‑Montiel6, Jose Diaz‑Chavez1 & Alfonso Duenas‑Gonzalez1,7* The malignant energetic demands are satisfed through glycolysis, glutaminolysis and de novo synthesis of fatty acids, while the host curses with a state of catabolism and systemic infammation. The concurrent inhibition of both, tumor anabolism and host catabolism, and their efect upon tumor growth and whole animal metabolism, have not been evaluated. We aimed to evaluate in colon cancer cells a combination of six agents directed to block the tumor anabolism (orlistat + lonidamine + DON) and the host catabolism (growth hormone + insulin + indomethacin). Treatment reduced cellular viability, clonogenic capacity and cell cycle progression. These efects were associated with decreased glycolysis and oxidative phosphorylation, leading to a quiescent energetic phenotype, and with an aberrant transcriptomic landscape showing dysregulation in multiple metabolic pathways. The in vivo evaluation revealed a signifcant tumor volume inhibition, without damage to normal tissues. The six‑drug combination preserved lean tissue and decreased fat loss, while the energy expenditure got decreased. Finally, a reduction in gene expression associated with thermogenesis was observed. Our fndings demonstrate that the simultaneous use of this six‑drug combination has anticancer efects by inducing a quiescent energetic phenotype of cultured cancer cells. Besides, the treatment is well‑ tolerated in mice and reduces whole animal energetic expenditure and fat loss.
    [Show full text]
  • Robert Shine, Peter Dwyer, Lyndsay Olson, Jennifer Truong, Matthew Goddeeris, Effie Tozzo, Eric Bell Mitobridge, Inc
    Poster Title Here Mitochondrial Deficiency in Primary Muscle Cells from Mdx Mice Robert Shine, Peter Dwyer, Lyndsay Olson, Jennifer Truong, Matthew Goddeeris, Effie Tozzo, Eric Bell Mitobridge, Inc. Cambridge, MA 02138 Abstract Results Results Duchenne muscular dystrophy (DMD) is a recessive, fatal X-linked disease that is characterized M ito c h o n d ria l c o n trib u te d A T P is re d u c e d Mdx myoblasts have decreased expression by progressive skeletal muscle wasting due to a loss of function in dystrophin, a protein that is of OXPHOS complexes part of a complex that bridges the cytoskeleton and extracellular matrix. The mdx mouse, an in m d x m y o b la s ts a n d m y o tu b e s T animal model for DMD, has a point mutation in the dystrophin gene that results in a loss of 1 .5 2.0 W l function. This study uses primary muscle satellite cell derived myoblasts and myotubes to W T a WT m determine differences in mitochondrial biology between the mdx mice and wild type (WT) control s M D X o 1.5 a r MDX mice. Compared to cells isolated from WT mice, mdx cells have reductions in mitochondrial 1 .0 **** f B bioenergetics. Moreover, mdx cells have reduced levels of mitochondria which may partially *** e T g 1.0 explain the reduction in bioenergetics. Interestingly, the mitochondrial phenotype is apparent **** ** n * * W a * * * before dystrophin protein is increased during myogenesis. * * * 0 .5 h 0.5 * d l C o d l F 0.0 o 1 3 2 6 1 a 1 a b B 0 .0 F t v Materials and Analysis a 5 P X D C H H y 5 l l F X T N R O D a M in a M in D C s s P n n U A c c O S C C a 0 a 0 S y y T B 0 B 0 D WT and mdx myoblast isolation and culture: Quadricep and gastrocnemius muscles from a C 1 m 1 m Q A o o N single mouse were pooled and subjected to a mechanical/collagenase digestion.
    [Show full text]
  • Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: an Update
    International Journal of Molecular Sciences Review Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update Philippe Icard 1,2,3,*, Antoine Coquerel 1,4, Zherui Wu 5 , Joseph Gligorov 6, David Fuks 7, Ludovic Fournel 3,8, Hubert Lincet 9,10 and Luca Simula 11 1 Medical School, Université Caen Normandie, CHU de Caen, 14000 Caen, France; [email protected] 2 UNICAEN, INSERM U1086 Interdisciplinary Research Unit for Cancer Prevention and Treatment, Normandie Université, 14000 Caen, France 3 Service de Chirurgie Thoracique, Hôpital Cochin, Hôpitaux Universitaires Paris Centre, APHP, Paris-Descartes University, 75014 Paris, France; [email protected] 4 INSERM U1075, COMETE Mobilités: Attention, Orientation, Chronobiologie, Université Caen, 14000 Caen, France 5 School of Medicine, Shenzhen University, Shenzhen 518000, China; [email protected] 6 Oncology Department, Tenon Hospital, Pierre et Marie Curie University, 75020 Paris, France; [email protected] 7 Service de Chirurgie Digestive et Hépato-Biliaire, Hôpital Cochin, Hôpitaux Universitaires Paris Centre, APHP, Paris-Descartes University, 75014 Paris, France; [email protected] 8 Descartes Faculty of Medicine, University of Paris, Paris Center, 75006 Paris, France 9 INSERM U1052, CNRS UMR5286, Cancer Research Center of Lyon (CRCL), 69008 Lyon, France; [email protected] 10 ISPB, Faculté de Pharmacie, Université Lyon 1, 69373 Lyon, France 11 Department of Infection, Immunity and Inflammation, Institut Cochin, INSERM U1016, CNRS UMR8104, Citation: Icard, P.; Coquerel, A.; Wu, University of Paris, 75014 Paris, France; [email protected] Z.; Gligorov, J.; Fuks, D.; Fournel, L.; * Correspondence: [email protected] Lincet, H.; Simula, L.
    [Show full text]
  • PIM2-Mediated Phosphorylation of Hexokinase 2 Is Critical for Tumor Growth and Paclitaxel Resistance in Breast Cancer
    Oncogene (2018) 37:5997–6009 https://doi.org/10.1038/s41388-018-0386-x ARTICLE PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer 1 1 1 1 1 2 2 3 Tingting Yang ● Chune Ren ● Pengyun Qiao ● Xue Han ● Li Wang ● Shijun Lv ● Yonghong Sun ● Zhijun Liu ● 3 1 Yu Du ● Zhenhai Yu Received: 3 December 2017 / Revised: 30 May 2018 / Accepted: 31 May 2018 / Published online: 9 July 2018 © The Author(s) 2018. This article is published with open access Abstract Hexokinase-II (HK2) is a key enzyme involved in glycolysis, which is required for breast cancer progression. However, the underlying post-translational mechanisms of HK2 activity are poorly understood. Here, we showed that Proviral Insertion in Murine Lymphomas 2 (PIM2) directly bound to HK2 and phosphorylated HK2 on Thr473. Biochemical analyses demonstrated that phosphorylated HK2 Thr473 promoted its protein stability through the chaperone-mediated autophagy (CMA) pathway, and the levels of PIM2 and pThr473-HK2 proteins were positively correlated with each other in human breast cancer. Furthermore, phosphorylation of HK2 on Thr473 increased HK2 enzyme activity and glycolysis, and 1234567890();,: 1234567890();,: enhanced glucose starvation-induced autophagy. As a result, phosphorylated HK2 Thr473 promoted breast cancer cell growth in vitro and in vivo. Interestingly, PIM2 kinase inhibitor SMI-4a could abrogate the effects of phosphorylated HK2 Thr473 on paclitaxel resistance in vitro and in vivo. Taken together, our findings indicated that PIM2 was a novel regulator of HK2, and suggested a new strategy to treat breast cancer. Introduction ATP molecules.
    [Show full text]
  • The Pathogenetic Role of Β-Cell Mitochondria in Type 2 Diabetes
    236 3 Journal of M Fex et al. Mitochondria in β-cells 236:3 R145–R159 Endocrinology REVIEW The pathogenetic role of β-cell mitochondria in type 2 diabetes Malin Fex1, Lisa M Nicholas1, Neelanjan Vishnu1, Anya Medina1, Vladimir V Sharoyko1, David G Nicholls1, Peter Spégel1,2 and Hindrik Mulder1 1Department of Clinical Sciences in Malmö, Unit of Molecular Metabolism, Lund University Diabetes Centre, Clinical Research Center, Malmö University Hospital, Lund University, Malmö, Sweden 2Department of Chemistry, Center for Analysis and Synthesis, Lund University, Sweden Correspondence should be addressed to H Mulder: [email protected] Abstract Mitochondrial metabolism is a major determinant of insulin secretion from pancreatic Key Words β-cells. Type 2 diabetes evolves when β-cells fail to release appropriate amounts f TCA cycle of insulin in response to glucose. This results in hyperglycemia and metabolic f coupling signal dysregulation. Evidence has recently been mounting that mitochondrial dysfunction f oxidative phosphorylation plays an important role in these processes. Monogenic dysfunction of mitochondria is a f mitochondrial transcription rare condition but causes a type 2 diabetes-like syndrome owing to β-cell failure. Here, f genetic variation we describe novel advances in research on mitochondrial dysfunction in the β-cell in type 2 diabetes, with a focus on human studies. Relevant studies in animal and cell models of the disease are described. Transcriptional and translational regulation in mitochondria are particularly emphasized. The role of metabolic enzymes and pathways and their impact on β-cell function in type 2 diabetes pathophysiology are discussed. The role of genetic variation in mitochondrial function leading to type 2 diabetes is highlighted.
    [Show full text]
  • Ketoconazole and Posaconazole Selectively Target HK2-Expressing Glioblastoma Cells
    Published OnlineFirst October 15, 2018; DOI: 10.1158/1078-0432.CCR-18-1854 Translational Cancer Mechanisms and Therapy Clinical Cancer Research Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells Sameer Agnihotri1, Sheila Mansouri2, Kelly Burrell2, Mira Li2, Mamatjan Yasin, MD2, Jeff Liu2,3, Romina Nejad2, Sushil Kumar2, Shahrzad Jalali2, Sanjay K. Singh2, Alenoush Vartanian2,4, Eric Xueyu Chen5, Shirin Karimi2, Olivia Singh2, Severa Bunda2, Alireza Mansouri7, Kenneth D. Aldape2,6, and Gelareh Zadeh2,7 Abstract Purpose: Hexokinase II (HK2) protein expression is eleva- in vivo. Treatment of mice bearing GBM with ketoconazole ted in glioblastoma (GBM), and we have shown that HK2 and posaconazole increased their survival, reduced tumor could serve as an effective therapeutic target for GBM. Here, we cell proliferation, and decreased tumor metabolism. In interrogated compounds that target HK2 effectively and addition, treatment with azoles resulted in increased pro- restrict tumor growth in cell lines, patient-derived glioma stem portion of apoptotic cells. cells (GSCs), and mouse models of GBM. Conclusions: Overall, we provide evidence that azoles exert Experimental Design: We performed a screen using a set of their effect by targeting genes and pathways regulated by HK2. 15 drugs that were predicted to inhibit the HK2-associated These findings shed light on the action of azoles in GBM. gene signature. We next determined the EC50 of the com- Combined with existing literature and preclinical results, these pounds by treating glioma cell lines and GSCs. Selected data support the value of repurposing azoles in GBM clinical compounds showing significant impact in vitro were used to trials.
    [Show full text]
  • Src Inhibitors Modulate Frataxin Protein Levels
    Human Molecular Genetics, 2015, Vol. 24, No. 15 4296–4305 doi: 10.1093/hmg/ddv162 Advance Access Publication Date: 6 May 2015 Original Article ORIGINAL ARTICLE Src inhibitors modulate frataxin protein levels Downloaded from https://academic.oup.com/hmg/article/24/15/4296/2453025 by guest on 28 September 2021 Fabio Cherubini1, Dario Serio1, Ilaria Guccini1, Silvia Fortuni1,2, Gaetano Arcuri1, Ivano Condò1, Alessandra Rufini1,2, Shadman Moiz1, Serena Camerini3, Marco Crescenzi3, Roberto Testi1,2 and Florence Malisan1,* 1Laboratory of Signal Transduction, Department of Biomedicine and Prevention, University of Rome ‘Tor Vergata’, Via Montpellier 1, 00133 Rome, Italy, 2Fratagene Therapeutics Ltd, 22 Northumberland Rd, Dublin, Ireland and 3Department of Cell Biology and Neurosciences, Italian National Institute of Health, Viale Regina Elena, 299, 00161 Rome, Italy *To whom correspondence should be addressed at: Laboratory of Signal Transduction, Department of Biomedicine and Prevention, University of Rome ‘Tor Vergata’, Via Montpellier 1, 00133 Rome, Italy. Tel: +39 0672596501; Fax: +39 0672596505; Email: [email protected] Abstract Defective expression of frataxin is responsible for the inherited, progressive degenerative disease Friedreich’s Ataxia (FRDA). There is currently no effective approved treatment for FRDA and patients die prematurely. Defective frataxin expression causes critical metabolic changes, including redox imbalance and ATP deficiency. As these alterations are known to regulate the tyrosine kinase Src, we investigated whether Src might in turn affect frataxin expression. We found that frataxin can be phosphorylated by Src. Phosphorylation occurs primarily on Y118 and promotes frataxin ubiquitination, a signal for degradation. Accordingly, Src inhibitors induce accumulation of frataxin but are ineffective on a non-phosphorylatable frataxin- Y118F mutant.
    [Show full text]
  • Aconitase: to Be Or Not to Be Inside Plant Glyoxysomes, That Is the Question
    biology Review Aconitase: To Be or not to Be Inside Plant Glyoxysomes, That Is the Question Luigi De Bellis 1,* , Andrea Luvisi 1 and Amedeo Alpi 2 1 Department of Biological and Environmental Sciences and Technologies, University of Salento, Via Prov. le Monteroni, I-73100 Lecce, Italy; [email protected] 2 Approaching Research Educational Activities (A.R.E.A.) Foundation, I-56126 Pisa, Italy; [email protected] * Correspondence: [email protected] Received: 10 June 2020; Accepted: 10 July 2020; Published: 12 July 2020 Abstract: After the discovery in 1967 of plant glyoxysomes, aconitase, one the five enzymes involved in the glyoxylate cycle, was thought to be present in the organelles, and although this was found not to be the case around 25 years ago, it is still suggested in some textbooks and recent scientific articles. Genetic research (including the study of mutants and transcriptomic analysis) is becoming increasingly important in plant biology, so metabolic pathways must be presented correctly to avoid misinterpretation and the dissemination of bad science. The focus of our study is therefore aconitase, from its first localization inside the glyoxysomes to its relocation. We also examine data concerning the role of the enzyme malate dehydrogenase in the glyoxylate cycle and data of the expression of aconitase genes in Arabidopsis and other selected higher plants. We then propose a new model concerning the interaction between glyoxysomes, mitochondria and cytosol in cotyledons or endosperm during the germination of oil-rich seeds. Keywords: aconitase; malate dehydrogenase; glyoxylate cycle; glyoxysomes; peroxisomes; β-oxidation; gluconeogenesis 1. Introduction Glyoxysomes are specialized types of plant peroxisomes containing glyoxylate cycle enzymes, which participate in the conversion of lipids to sugar during the early stages of germination in oilseeds.
    [Show full text]
  • Grantsummaries 2014-2017 Jf
    2015 FARA Awarded Grants Principal Investigator/Organization Grant Description Type of Research Co-funding Drug Discovery 2014 Keith Michael Andrus Cardiac Research Award: Veronique Monnier - Université Identification of therapeutic compounds on a cardiac Drosophila model of Friedreich’s Translational FARA Ireland Paris Diderot ataxia Andrew Dancis - University of A therapeutic strategy for Friedreich's ataxia: Frataxin bypass by enhancing the Translational Pennsylvania mitochondrial cysteine desulfurase activity Edward L. Grabczyk - Louisiana Small molecule induced exon skipping of MLH3 to slow repeat expansion in an FRDA Translational State University mousel model High throughput screen of Pfizer small molecule chemical library in FRDA patient- Pfizer Basic/Translational derived cells to look for regulators of frataxin protein Robert Wilson - University of (1) Center of Excellence: Drug Discovery Basic/Translational Hamilton & Finneran Family Pennsylvania (2) Drug testing and development for FA Omar Khdour - Arizona State Approaches to correct mitochondrial abnormalities and synaptic pathology in frataxin- Basic/Translational University deficient sensory neurons Gene & Stem Cell Therapy Helene Puccio - INSERM, IGBMC, Development of neuronal gene therapy for the treatment of FRDA Translational FARA Ireland France Ricardo Pinto Mouro - Harvard FARA Ireland & The National CRISPR/Cas9-based Therapeutics for Friedreich's ataxia Basic/Translational University Ataxia Foundation Joel Gottesfeld - The Scripps Stem Cell Therapeutics for Friedreich's
    [Show full text]
  • Inhibition of Aldehyde Dehydrogenase 2 by Oxidative Stress Is Associated with Cardiac Dysfunction in Diabetic Rats
    Inhibition of Aldehyde Dehydrogenase 2 by Oxidative Stress Is Associated with Cardiac Dysfunction in Diabetic Rats Jiali Wang,1,2* Haigang Wang,3* Panpan Hao,1,2 Li Xue,1,2 Shujian Wei,1,2 Yun Zhang,2,4 and Yuguo Chen1,2 1Department of Emergency, Qilu Hospital, Shandong University, Jinan, China; 2Key Laboratory of Cardiovascular Remodeling and Function Research affiliated to Ministry of Education of the China and Ministry of Health of the China, Shandong University, Jinan, China; 3Department of Pharmacy, Qilu Hospital, Shandong University, Jinan, China; and4Department of Cardiology, Qilu Hospital, Shandong University, Jinan, China Left ventricular (LV) dysfunction is a common comorbidity in diabetic patients, although the molecular mechanisms underlying this cardiomyopathic feature are not completely understood. Aldehyde dehydrogenase 2 (ALDH2) has been considered a key cardioprotective enzyme susceptible to oxidative inactivation. We hypothesized that hyperglycemia-induced oxidative stress would influence ALDH2 activity, and ALDH2 inhibition would lead to cardiac functional alterations in diabetic rats. Diabetes was in- duced by intraperitoneal (i.p.) injection of 60 mg/kg streptozotocin. Rats were divided randomly into four groups: control, untreated diabetic, diabetic treated with N-acetylcysteine (NAC) and diabetic treated with a-lipoic acid (α-LA). Cardiac contractile func- tion, oxidative stress markers and reactive oxygen species (ROS) levels were assessed. ALDH2 activity and expression also were de- termined. The role of ALDH2 activity in change in hyperglycemia-induced mitochondrial membrane potential (Δψ) was tested in cultured neonatal cardiomyocytes. Myocardial MDA content and ROS were significantly higher in diabetic rats than in controls, whereas GSH content and Mn-SOD activity were decreased in diabetic rats.
    [Show full text]